Mc Auley Mark T, Mooney Kathleen M
a School of Health Sciences, Liverpool Hope University, Taggart Avenue, Liverpool, L16 1JD, UK.
b Faculty of Health and Social Care, Edge Hill University, St Helens Road, Ormskirk, Lancashire, L39 4QP, UK.
Expert Rev Endocrinol Metab. 2014 Jul;9(4):357-367. doi: 10.1586/17446651.2014.921569. Epub 2014 May 31.
Populations in developed nations are aging gradually; it is predicted that by 2050 almost a quarter of the world's population will be over 60 years old, more than twice the figure at the turn of the 20th century. Although we are living longer, this does not mean the extra years will be spent in good health. Cardiovascular diseases are the primary cause of ill health and their prevalence increases with age. Traditionally, lipid biomarkers have been utilized to stratify disease risk and predict the onset of cardiovascular events. However, recent evidence suggests that hormonal interplay with lipid metabolism could have a significant role to play in modulating cardiovascular disease risk. This review will explore recent findings which have investigated the role hormones have on the dynamics of lipid metabolism. The aim is to offer an insight into potential avenues for therapeutic intervention.
发达国家的人口正在逐渐老龄化;据预测,到2050年,全球近四分之一的人口将超过60岁,这一数字是20世纪之交时的两倍多。尽管我们的寿命延长了,但这并不意味着额外的岁月会在健康状态下度过。心血管疾病是健康不佳的主要原因,其患病率会随着年龄的增长而增加。传统上,脂质生物标志物一直被用于对疾病风险进行分层,并预测心血管事件的发生。然而,最近的证据表明,激素与脂质代谢的相互作用可能在调节心血管疾病风险方面发挥重要作用。本综述将探讨最近的研究发现,这些发现调查了激素在脂质代谢动态中的作用。目的是深入了解潜在的治疗干预途径。